Identification of μ-opioid receptor epitopes recognized by agonistic IgG

Biochemical and Biophysical Research Communications

Volumn 280, Issue 4, 2001, Pages 1142-1147

  Macé, Gaëtane ^a   Jaume, Martial ^a   Druet, Elvira ^a   Blanpied, Catherine ^a   Nguyen, Christophe ^b   Druet, Philippe ^a   Dietrich, Gilles ^a  

^a INSERM   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Agonistic antibody; Binding site; G protein coupled receptor; opioid receptor

Indexed keywords

EPITOPE; FLUORINE; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MORPHINE; MU OPIATE RECEPTOR; PEPTIDE; YTTRIUM;

AGONIST; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; IMMUNIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SERUM;

EID: 0034815444     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4258     Document Type: Article

References (20)

1. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
2. Isolation and characterization of natural human IgG with a morphine-like activity
3. Morphine-like activity of natural human IgG autoantibodies is because of binding to the first and third extracellular loops of the μ-opioid receptor
4. Key residues defining the μ-opioid receptor binding pocket: A site-directed mutagenesis study
5. Conformational changes in rhodopsin. Movement of helix F detected by site-specific chemical labeling and fluorescence spectroscopy
6. G protein-coupled receptors. Mechanism of agonist activation
7. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints
8. A piston model for transmembrane signaling of the aspartate receptor
9. Structure-function analysis of the cloned opiate receptors: Peptide and small molecule interactions
10. Human kappa opiate receptor second extracellular loop elevates dynorphin′s affinity for human μ/κ chimeras
11. Location of regions of the opioid receptor involved in selective agonist binding
12. DAMGO, a μ-opioid receptor selective agonist, distinguishes between/μ- and δ-opioid receptors around their first extracellular loops
13. Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors
14. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ- and μ-opioid receptors
15. DAMGO, a μ-opioid receptor selective ligand, distinguishes between μ-and κ-opioid receptors at a different region from that for the distinction between μ- and δ-opioid receptors
16. The third extracellular loop of the μ opioid receptor is important for agonist selectivity
17. DAMGO recognizes four residues in the third extracellular loop to discriminate between μ and κ opioid receptors
18. Stereochemical requirements for receptor recognition of the μ-opioid peptide endomorphin-1
19. Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor
20. Implication of the first and third extracellular loops of the μ-opioid receptor in the formation of the ligand binding site: A study using chimeric μ-opioid/angiotensin receptors